Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (1018)	6/16/2006 10:26:55 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1336

I'm going to go for one more run in medicines, and then I'm going to bail. Absolutely sick, re. what came out of nbix this morning. I've been uninterested for ages, as the pipe came way too slowly and I didn't share PFE's enthusiasm for jimmying a molecule to fit what I perceive as two separate markets. aside....... Some comments of mine re. indiplon, Peter's thread, were taken out of intended context. I very rarely have trouble sleeping. I don't NEED any sleep aid. For some situations, I "need" an agent that has similar properties to fast-release indiplon. Ugh.

To: Mike McFarland who wrote (1018)	6/16/2006 2:49:42 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1336

Mike: qualifying.... >> and I didn't share PFE's enthusiasm for jimmying a molecule to fit what I perceive as two separate markets << I certainly did, once. Big-time, back in the days when I thought that NBIX stood a chance of hitting regulatory hurdles with SEPR. As the NBIX pipe floundered relative to some other companies and as SEPR kicked the crap out of Pfizer/nbix, I lost interest. Motley crew of stocks going up today. Ashamed today to be a biotech investor. Again. Rick